Sharpest

Iran war is driving up prices for fuel and raw materials, says survey Business live – latest updatesConstruction companies in the UK are experiencing some of the sharpest cost rises in nearly 30 years as the war in Iran drives up prices for fuel and raw materials, according to a closely watched survey.The poll of UK construction companies found that input cost inflation – which accounts for expenses such as raw materials, energy and labour – rose last month to the highest level since June 2022 when there was a spike in commodity prices caused by Russia’s invasion of Ukraine. Continue reading...

• Spyware detections against Singapore organisations more than doubled in 2025, marking the sharpest increase in the region amid escalating cyber threats. • Southeast Asia recorded an 18% rise in spyware attacks during the same period, indicating a broader regional vulnerability trend. • The surge underscores growing cybersecurity risks for businesses across the region and highlights the need for enhanced defensive measures and threat intelligence.

PMI figure reveals impact on economy of rise in oil prices driven by Iran warBusiness live – latest updatesThe UK’s manufacturers have suffered the sharpest one-month acceleration in costs since the aftermath of Black Wednesday in 1992, as conflict in the Middle East has driven up oil prices, new survey evidence shows.The closely watched purchasing managers’ index (PMI) lays bare the impact of the conflict on the UK economy, with growth slowing sharply across manufacturing and services and costs rising. Continue reading...

Biotech firm Immutep Ltd. crashed more than 80% on March 13, 2026, becoming one of the biggest decliners amid a mixed US market session pressured by geopolitical fears. The plunge contrasted with gains in AI leaders like Intel (+1.7%), Tesla (steady at $395), and Nokia (+1.4%), highlighting sector rotation. This extreme volatility amplifies risks in biotech amid elevated VIX at 26.49 and weekly index losses. Investors may monitor clinical trial updates or funding news for rebound potential.